To attenuate atherosclerosis, inhibition of miR-29a is an effective therapeutic approach by modulating the KLF5/miR-29a/Fbw7/CDC4/KLF5 positive feedback loop (82). This evidence concerns the gene KLF5 and atherosclerosis.